Trestle Biotherapeutics

Trestle Biotherapeutics, Inc. is a pre-clinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.

Profile Description

Our team has been building a new company that we’re really proud to share with you – Trestle Biotherapeutics. The mission at Trestle is something that we’ve been thinking about for a long time, and we believe it will transform the lives of patients with kidney disease. If we get this right, the solutions we develop can be used to help millions of patients suffering from other types of organ failure.

The naming of Trestle carries many meanings for us. A trestle is a bridge which rests on the support of underlying and interconnected braces. That bridge allows continuation of a journey and enables the path to go on. We see the patients we aim to treat getting across. We also see it as a way to bridge scientific disciplines, to achieve what is only possible at their intersect. Lastly, we know there are smart people across the globe that we intend to bridge together, so they can contribute to what we’re building.

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services